Safe and Affordable Drugs from Canada Act of 2017
- Last Action
- 1/10/2017
Actions
- 2017-01-10Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
- 2017-01-10Introduced in Senate
CRS Summary
As of 2017-01-10 (00)
Safe and Affordable Drugs from Canada Act of 2017
This bill amends the Federal Food, Drug, and Cosmetic Act (FFDCA) to require the Department of Health and Human Services (HHS) to promulgate regulations within 185 days permitting individuals to import a prescription drug purchased from an approved Canadian pharmacy that:
- is dispensed by a pharmacist licensed in Canada;
- is purchased for personal use in quantities not greater than a 90-day supply;
- is filled using a valid prescription issued by a physician licensed to practice in the United States; and
- has the same active ingredients, route of administration, dosage form, and strength as a prescription drug approved under the FFDCA.
Certain medications may not be imported, including controlled substances and biological products.
The bill establishes a certification process for approving Canadian pharmacies. HHS must publish a list of approved Canadian pharmacies.
Cosponsors (10)
- Amy Klobuchar (D-MN)
- Charles Grassley (R-IA)
- Patrick Leahy (D-VT)
- Angus King (I-ME)
- Sheldon Whitehouse (D-RI)
- Sherrod Brown (D-OH)
- Tammy Baldwin (D-WI)
- Jeanne Shaheen (D-NH)
- Jeff Merkley (D-OR)
- Maggie Hassan (D-NH)
Subjects
- Administrative law and regulatory procedures
- Canada
- Department of Health and Human Services
- Drug safety, medical device, and laboratory regulation
- Government information and archives
- Prescription drugs
- Trade restrictions
Sourced from Congress.gov (public domain).
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.